Used primarily as a key intermediate in pharmaceutical synthesis, especially in Suzuki-Miyaura cross-coupling reactions to construct biaryl structures. Its boronate ester group enables efficient carbon-carbon bond formation under mild conditions, making it valuable in the development of active pharmaceutical ingredients (APIs). The presence of both amine and fluoro groups allows for further functionalization, enhancing its utility in drug discovery and the preparation of complex organic molecules. Commonly employed in the synthesis of kinase inhibitors and other bioactive compounds where substituted anilines are required.